Marco Ritelli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

Cells

Vascular medicine (London, England)

Molecular genetics & genomic medicine

American journal of medical genetics. Part A

Universita' degli Studi di BRESCIA

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universita' degli Studi di BRESCIA Dec 01 2018 - Dec 01 2021

Italy

Ricercatori a tempo determinato :: Dipartimento di Medicina Molecolare e Traslazionale

Universita' degli Studi di BRESCIA Sep 25 2017 - Apr 30 2019

Italy

Altri :: Dipartimento di Scienze Cliniche e Sperimentali

Universita' degli Studi di BRESCIA Mar 02 2015 - Feb 28 2017

Italy

Altri :: Dipartimento di Medicina Molecolare e Traslazionale

Universita' degli Studi di BRESCIA Apr 01 2014 - Mar 31 2015

Italy

Collaboratori :: Dipartimento di Medicina Molecolare e Traslazionale

Universita' degli Studi di BRESCIA Mar 01 2013 - Feb 28 2014

Italy

Collaboratori :: Dipartimento di Medicina Molecolare e Traslazionale

Universita' degli Studi di BRESCIA Jan 16 2012 - Jan 16 2013

Italy

Collaboratori :: EX-Dipartimento Scienze Biomediche e Biotecnologie-(1900/2012)

Universita' degli Studi di BRESCIA Dec 16 2010 - Dec 16 2011

Italy

Collaboratori :: EX-Dipartimento Scienze Biomediche e Biotecnologie-(1900/2012)

Universita' degli Studi di BRESCIA Dec 01 2009 - Dec 16 2011

Italy

Collaboratori :: EX-Dipartimento Scienze Biomediche e Biotecnologie-(1900/2012)

Universita' degli Studi di BRESCIA Jan 01 2008 - Dec 01 2009

Italy

Assegnisti :: EX-Dipartimento Scienze Biomediche e Biotecnologie-(1900/2012)

Universita' degli Studi di BRESCIA Jul 01 2004 - Jan 01 2008

Italy

Personale esterno ed autonomi :: EX-Dipartimento Scienze Biomediche e Biotecnologie-(1900/2012)

Universita' degli Studi di BRESCIA Feb 12 2006 - Feb 18 2006

Italy

Collaboratori :: EX-Dipartimento Scienze Biomediche e Biotecnologie-(1900/2012)

Universita' degli Studi di BRESCIA Dec 01 2002 - Jul 01 2004

Italy

Collaboratori :: EX-Dipartimento Scienze Biomediche e Biotecnologie-(1900/2012)

Publications

Marco Ritelli, Nicola Chiarelli, Valeria Cinquina, Valeria Bertini, Silvia Piantoni, Alessia Caproli, Silvia Ebe Lucia Della Pinna, Franco Franceschini, Guido Zarattini, Woodrow Gandy, Marina Venturini, Nicoletta Zoppi, Marina Colombi
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker. American journal of medical genetics. Part A (2024)
Marco Ritelli, Nicola Chiarelli, Valeria Cinquina, Marika Vezzoli, Marina Venturini, Marina Colombi
Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center. American journal of medical genetics. Part A (2023)
Giacomo Buso, Anna Paini, Claudia Agabiti-Rosei, Carolina De Ciuceis, Fabio Bertacchini, Deborah Stassaldi, Massimo Salvetti, Marco Ritelli, Marina Venturini, Marina Colombi, Maria Lorenza Muiesan
Despite celiprolol therapy, patients with vascular Ehlers-Danlos syndrome remain at risk of vascular events: A 12-year experience in an Italian referral center. Vascular medicine (London, England) (2023)
Giacomo Buso, Anna Paini, Claudia Agabiti-Rosei, Carolina De Ciuceis, Fabio Bertacchini, Deborah Stassaldi, Massimo Salvetti, Marco Ritelli, Marina Venturini, Marina Colombi, Maria Lorenza Muiesan
Despite celiprolol therapy, patients with vascular Ehlers-Danlos syndrome remain at risk of vascular events: A 12-year experience in an Italian referral center. Vascular medicine (London, England) 29 (3) (2023)
Marco Ritelli, Nicola Chiarelli, Valeria Cinquina, Nicoletta Zoppi, Valeria Bertini, Marina Venturini, Marina Colombi
RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms. Cells 11 (24) (2022)
Marco Ritelli, Nicola Chiarelli, Valeria Cinquina, Nicoletta Zoppi, Valeria Bertini, Marina Venturini, Marina Colombi
RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms. Cells 11 (24) (2022)
Marco Ritelli, Nicola Chiarelli, Valeria Cinquina, Nicoletta Zoppi, Valeria Bertini, Marina Venturini, Marina Colombi
RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms. Cells 11 (24) (2022)
Marco Ritelli, Nicola Chiarelli, Valeria Cinquina, Nicoletta Zoppi, Valeria Bertini, Marina Venturini, Marina Colombi
RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms. Cells 11 (24) (2022)
Nicola Chiarelli, Nicoletta Zoppi, Marina Venturini, Daniele Capitanio, Cecilia Gelfi, Marco Ritelli, Marina Colombi
Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target? Cells 10 (11) (2021)
Juan Li, Marco Ritelli, Cindy S Ma, Geetha Rao, Tanwir Habib, Emilie Corvilain, Salim Bougarn, Sophie Cypowyj, Lucie Grodecká, Romain Levy, Vivien Béziat, Lei Shang, Kathryn J Payne, Danielle T Avery, Mélanie Migaud, Soraya Boucherit, Sabri Boughorbel, Andrea Guennoun, Maya Chrabieh, Franck Rapaport, Benedetta Bigio, Yuval Itan, Bertrand Boisson, Valérie Cormier-Daire, Delfien Syx, Fransiska Malfait, Nicoletta Zoppi, Laurent Abel, Tomas Freiberger, Harry C Dietz, Nico Marr, Stuart G Tangye, Marina Colombi, Jean Laurent Casanova, Anne Puel
Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β. Science immunology 4 (41) (2020)
Marco Ritelli, Valeria Cinquina, Marina Venturini, Marina Colombi
Identification of the novel COL5A1 c.3369_3431dup, p.(Glu1124_Gly1144dup) variant in a patient with incomplete classical Ehlers-Danlos syndrome: The importance of phenotype-guided genetic testing. Molecular genetics & genomic medicine 8 (10) (2020)
Valeria Cinquina, Claudia Ciaccio, Marina Venturini, Riccardo Masson, Marco Ritelli, Marina Colombi
Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa. Molecular genetics & genomic medicine 9 (1) (2020)
Chloe Angwin, Angela F Brady, Marina Colombi, David J P Ferguson, Rebecca Pollitt, F Michael Pope, Marco Ritelli, Sofie Symoens, Neeti Ghali, Fleur S van Dijk
Absence of Collagen Flowers on Electron Microscopy and Identification of (Likely) Pathogenic COL5A1 Variants in Two Patients. Genes 10 (10) (2019)
Daisy Rymen, Marco Ritelli, Nicoletta Zoppi, Valeria Cinquina, Cecilia Giunta, Marianne Rohrbach, Marina Colombi
Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant. Genes 10 (11) (2019)
Marco Ritelli, Chiara Rovati, Marina Venturini, Nicola Chiarelli, Valeria Cinquina, Marco Castori, Marina Colombi
Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology. Clinical genetics 97 (2) (2019)

Marco Ritelli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Ritelli